Who are ATB Therapeutics's investors?

ATB Therapeutics's investors include MRL Ventures Fund, V-Bio Ventures, VIVES Partners, EQT Life Sciences, Sambrinvest, Wallonie Entreprendre.

ATB Therapeutics

Founded 2018 · 38 employees on LinkedIn · 6 known investors

Find your way into ATB Therapeutics

ATB Therapeutics is a biotech company developing bispecific antibody therapies and related immunological treatments. The company operates in the preclinical and clinical stage biotechnology space.

Biotech Healthtech Medical Devices

Founders & leadership

Dr. Mark ThrosbyChief Executive Officer

Investors · 6

MRL Ventures Fund✓ verifiedCambridge · $25M

V-Bio Ventures✓ verifiedGhent · $270K – $2.2M

VIVES Partners✓ verifiedWavre · $108K – $7.6M

EQT Life Sciences✓ verifiedLuxembourg · $11M – $66M

Sambrinvest✓ verifiedCharleroi

Wallonie Entreprendre✓ verifiedLiège

Frequently asked questions

What does ATB Therapeutics do?: ATB Therapeutics is a biotech company developing bispecific antibody therapies and related immunological treatments. The company operates in the preclinical and clinical stage biotechnology space.
Who are ATB Therapeutics's investors?: ATB Therapeutics's investors include MRL Ventures Fund, V-Bio Ventures, VIVES Partners, EQT Life Sciences, Sambrinvest, Wallonie Entreprendre.